Gemina Laboratories Ltd. (TSE:GLAB) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Gemina Laboratories Ltd. has successfully raised $435,000 through the exercise of common share purchase warrants and has also settled a $40,000 debt with lenders by issuing 100,000 common shares at a discounted price. The company is known for its innovative biosensor and diagnostic technology, which is currently being developed for rapid testing of various pathogens, including COVID-19 and influenza.
For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue